
    
      MC-1101is a topically administered drug which in previous clinical studies has been proven to
      get to the back of the eye. MC-1101is a 505 (b) 2 compound and has FDA Fast Track Status. It
      is a strong, vasoactive drug which is intended to increase choroidal blood flow.
    
  